1. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019;Safiri;BMJ,2022
2. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities;Bourdin;Eur Respir Rev,2009
3. Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study;Pradhan;BMJ,2022
4. Association of sodium-glucose cotransporter 2 inhibitor vs dipeptidyl peptidase-4 inhibitor use with risk of incident obstructive airway disease and exacerbation events among patients with type 2 diabetes in Hong Kong;Au;JAMA Netw Open,2023
5. Are high- or low-dose SGLT2 inhibitors associated with cardiovascular and respiratory adverse events? A meta-analysis;Zou;J Cardiovasc Pharmacol,2022